down arrow

Guangdong Marubi Biotechnology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: FMCG
  • ISIN: CNE100003M51
CNY
34.17
-0.65 (-1.87%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Guangdong Marubi Biotechnology Co., Ltd.
Why is Guangdong Marubi Biotechnology Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.77% and Operating profit at -6.51% over the last 5 years
2
With ROE of 10.47%, it has a very attractive valuation with a 4.75 Price to Book Value
  • Over the past year, while the stock has generated a return of 14.28%, its profits have risen by 33.1% ; the PEG ratio of the company is 1.4
  • At the current price, the company has a high dividend yield of 1.9
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guangdong Marubi Biotechnology Co., Ltd. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Guangdong Marubi Biotechnology Co., Ltd.
14.28%
0.36
44.88%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.77%
EBIT Growth (5y)
-6.51%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.66
Tax Ratio
12.02%
Dividend Payout Ratio
88.04%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.44%
ROE (avg)
8.86%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
45
Industry P/E
Price to Book Value
4.75
EV to EBIT
40.99
EV to EBITDA
37.22
EV to Capital Employed
7.59
EV to Sales
4.33
PEG Ratio
1.37
Dividend Yield
1.88%
ROCE (Latest)
18.51%
ROE (Latest)
10.47%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
ROCE(HY)

Highest at 10.5%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -2.42% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 51.9%

NET SALES(Q)

At CNY 840.19 MM has Grown at 28.14%

OPERATING PROFIT(Q)

Highest at CNY 154.23 MM

OPERATING PROFIT MARGIN(Q)

Highest at 18.36 %

PRE-TAX PROFIT(Q)

Highest at CNY 165.96 MM

NET PROFIT(Q)

Highest at CNY 134.89 MM

EPS(Q)

Highest at CNY 0.34

-8What is not working for the Company
INTEREST(HY)

At CNY 6.72 MM has Grown at 151.48%

Here's what is working for Guangdong Marubi Biotechnology Co., Ltd.
Net Sales
At CNY 840.19 MM has Grown at 28.14%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit
Highest at CNY 154.23 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin
Highest at 18.36 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at CNY 165.96 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 134.89 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.34
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio
Highest at 51.9%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -2.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Guangdong Marubi Biotechnology Co., Ltd.
Interest
At CNY 6.72 MM has Grown at 151.48%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."